A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

NCT00359359 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Small Cell

Interventions

DRUG: Sagopilone (BAY86-5302, ZK 219477)
DRUG: Cisplatin

Sponsor

Bayer